Correlation Between Geron and Amplia Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Geron and Amplia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Geron and Amplia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Geron and Amplia Therapeutics Limited, you can compare the effects of market volatilities on Geron and Amplia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Geron with a short position of Amplia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Geron and Amplia Therapeutics.

Diversification Opportunities for Geron and Amplia Therapeutics

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Geron and Amplia is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Geron and Amplia Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amplia Therapeutics and Geron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Geron are associated (or correlated) with Amplia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amplia Therapeutics has no effect on the direction of Geron i.e., Geron and Amplia Therapeutics go up and down completely randomly.

Pair Corralation between Geron and Amplia Therapeutics

Given the investment horizon of 90 days Geron is expected to generate 6.47 times less return on investment than Amplia Therapeutics. But when comparing it to its historical volatility, Geron is 3.25 times less risky than Amplia Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Amplia Therapeutics Limited is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  4.00  in Amplia Therapeutics Limited on September 2, 2024 and sell it today you would earn a total of  1.80  from holding Amplia Therapeutics Limited or generate 45.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Geron  vs.  Amplia Therapeutics Limited

 Performance 
       Timeline  
Geron 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Geron has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Geron is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Amplia Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Amplia Therapeutics Limited are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting primary indicators, Amplia Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Geron and Amplia Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Geron and Amplia Therapeutics

The main advantage of trading using opposite Geron and Amplia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Geron position performs unexpectedly, Amplia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amplia Therapeutics will offset losses from the drop in Amplia Therapeutics' long position.
The idea behind Geron and Amplia Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stocks Directory
Find actively traded stocks across global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Managers
Screen money managers from public funds and ETFs managed around the world
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins